Become a Patron!

Drugmakers’ deal making will plow ahead despite antitrust scrutiny, analysts say

Status
Not open for further replies.

VUBot

Staff member
Diamond Contributor
ECF Refugee
Vape Media
Drugmakers’ deal making will plow ahead despite antitrust scrutiny, analysts say


The brisk pace of biopharmaceutical deal making seen in the first half of this year may only accelerate in the months ahead, even as regulators take a hard look at some of the bigger deals, analysts say. While the Federal Trade Commission’s recent challenge to Amgen Inc.’s AMGN, acquisition of…

#amgenincs #amgn #ftc #amgen #evandavidseigerman #bmocapitalmarkets #pfizer #pfe #seagen #elilillycos

Continue reading...
 
Status
Not open for further replies.

VU Sponsors

Top